Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Mais filtros










Base de dados
Intervalo de ano de publicação
1.
Chem Commun (Camb) ; 59(100): 14835-14838, 2023 Dec 14.
Artigo em Inglês | MEDLINE | ID: mdl-38014495

RESUMO

We report the synthesis and characterization of two new fluorophores, consisting of a [8]cyclo-para-phenylene core in which two phenylenes are bridged by either a nitrogen atom or a carbonyl group. The nitrogen bridge increases the HOMO-LUMO gap, whereas the carbonyl bridge decreases it. These results provide guidelines to control the electronic properties of nanohoops.

2.
Vaccine ; 34(48): 5878-5885, 2016 11 21.
Artigo em Inglês | MEDLINE | ID: mdl-27997338

RESUMO

The selection of a cell substrate is a critical step for the development and manufacturing of a viral vaccine candidate. Several parameters such as cell susceptibility and permissiveness to the viral pathogens but also performance in terms of viral antigens quality and production yields are important considerations when identifying the ideal match between a viral vaccine and cell substrate. The modified vaccinia virus Ankara (MVA) is a replication-deficient viral vector that holds great promise as a vaccine platform, however only limited cell substrates have been tested or are available for industrialization. Here we evaluate the duck embryo-derived EB66® cell line as potential cell substrate for MVA production. To this end, we used two recombinant MVA constructs and demonstrated that EB66® cells are propagating the tested MVA viruses very efficiently, while preserving viral attenuation and transgene expression for up to 20 serial passages. Furthermore we developed upstream and downstream processes that enable industrialization of the virus production. In conclusion, we showed that EB66® cells can be used as potent cell substrate for MVA-based vaccines and represent therefore an attractive alternative for vaccine production.


Assuntos
Vaccinia virus/genética , Vaccinia virus/fisiologia , Vacinas Virais , Cultura de Vírus , Replicação Viral , Animais , Antígenos Virais , Linhagem Celular , Patos , Embrião não Mamífero/citologia , Humanos , Inoculações Seriadas , Transgenes , Vacinas Atenuadas , Vacinas de DNA , Vaccinia virus/imunologia , Vaccinia virus/patogenicidade
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...